Polymer Capital Management (Hk) LTD Catalent, Inc. Transaction History

Polymer Capital Management (Hk) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $535,800 - $570,200	10,000 Added 16.67%	70,000 $3.94 Billion
Q1 2024 May 13, 2024	BUY	$42.56 - $59.82 $1.06 Million - $1.5 Million	25,000 Added 71.43%	60,000 $3.39 Billion
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $1.13 Million - $1.63 Million	35,000 New	35,000 $1.57 Billion

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Polymer Capital Management (Hk) LTD, based on Form 13F filings with the SEC.

Stay updated on Polymer Capital Management (Hk) LTD with notifications on news.